Unveiling the Power of Traditional Soodha Vallathi Urundai against Gastric Cancer Cells
DOI:
https://doi.org/10.63682/jns.v14i32S.7886Keywords:
Balb/c mice, MKN-45Ptumor cells, Biochemical test, ImmunohistochemistryAbstract
Introduction: Cancer-related deaths from gastric cancer (GC) are significant worldwide, and there is an urgent need for new, efficient therapies. Siddha medicine, known for its extensive historical use, presents potential anticancer compounds. Soodha Vallathi Urundai (SVU) is a time- honored remedy believed to have healing benefits; however, its effect on gastric cancer remains largely unexplored. This study aimed to assess the anticancer efficacy of SVU in a gastric cancer model (MKN-45P), focusing on tumor development, angiogenesis, blood parameters, and metabolic indicators.
Methodology: Three groups of Balb/c mice (n=6) received injections of MKN-45P tumor cells and then administered SVU (200 mg/kg). Tumor advancement and blood were assessed, including biochemical tests, immunohistochemistry for CD31, LDH, and TNF-α, and white blood cell counts, were performed.
Results: SVU treatment markedly inhibited tumor growth (tumor size in the SVU-treated group: 2.45 ± 0.63 cm versus 3.02 ± 0.73 cm in the MKN-45P group, p < 0.05). The phrase of CD31 in tumors was reduced in SVU-treated sector (0.32 ± 0.12) relative to the MKN-45P group (0.72 ± 0.21, p < 0.01). Haematological examination showed elevated WBC levels (14.1 ± 0.754 ×10³/µL in the SVU-treated group compared to 11.2 ± 1.58 ×10³/µL in the MKN-45P group, p < 0.05). LDH levels were considerably lower in SVU group (0.136 ± 0.024 IU/L compared to 0.226 ± 0.0115 IU/L in the MKN-45P group, p < 0.01).
Conclusions: SVU showed notable anticancer effects, decreasing tumor size, angiogenesis, and metabolic indicators, while enhancing immune response with minimal toxicity. These findings indicate that SVU may be a viable treatment option for gastric cancer, necessitating additional research.
Downloads
Metrics
References
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394-424, 2018.
Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet 388(10060):2654-2664, 2016.
Thillaivanan S, Samraj K. Challenges, constraints and opportunities in herbal medicines – A review. Int J Herbal Med 1(1):1-5, 2012.
Kim DH, Kim SD, Jun HJ, et al. Effectiveness and safety of combined treatment with herbal medicines and palliative chemotherapy for advanced gastric cancer: A systematic review and meta-analysis. Integr Med Res 14(1):101098, 2024.
Govindarajan R, Vijayakumar M, Pushpangadan P. Antioxidant approach to disease management and the role of 'Rasayana' herbs of Ayurveda. J Ethnopharmacol; 132(1):165-178, 2010.
Wu C, Mulakaluri A, Chaurasia P, et al. A scoping review of Ayurvedic rasayana adaptogens in oncology. J Ayurveda Integr Med 15(1):100879, 2024.
Selvam AB, Babu SC, Rajeswari R. Ethnobotanical survey of medicinal plants used by traditional healers in Yercaud hills of Eastern Ghats, India. J Ethnopharmacol 164:1-12, 2015.
Rajendran A, Sekar T. Documentation of folk medicinal plants used by Palliyar tribals of Sadhuragiri Hills, Tamil Nadu, Southern India. Asian Pac J Trop Biomed 3(12):1016-1020, 2013.
Matsui Y, Inomata M, Tojigamori M, et al. Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti-HER2 antibody in a murine model. Int J Oncol 27:81, 2005.
Zhang W, Anker L, Law RE, et al. Enhancement of radio sensitivity in human malignant glioma cells by hypericin in vitro. Clin Cancer Res 2(5):843-846, 1996.
Hu L, Hofmann J, Holash J, et al. Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model. Clin Cancer Res11:6966, 2005.
Sako A, Kitayama J, Shida D, et al. Lysophosphatidic acid (LPA)-induced vascular endothelial growth factor (VEGF) by mesothelial cells and quantification of host-derived VEGF in malignant ascites. J Surg Res 130:94, 2006.
Ueda K, Iwahashi M, Matsuura I, et al. Adenoviral-mediated gene transduction of the hepatocyte growth factor (HGF) antagonist, NK4, suppresses peritoneal metastases of gastric cancer in nude mice. Eur J Cancer 40:2135, 2004.
Lv G, Zhang Y, Sun P, et al. Prognostic value of serum lactate dehydrogenase in gastric cancer patients. Cancer Manag Res 12:5951-5960, 2020.
Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev 28(1-2):33-40, 2009.
Lang SA, Gaumann A, Koehl GE, et al. Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model. Int J Cancer 120:1803, 2007.
Liu W, Liu W, Zou H, et al. Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma. J Immunother Cancer 12(4):e008857, 2024.
Pugh ND, Tamta H, Balachandran P, et al. Immune-enhancing effects of Echinacea purpurea extract: Modulation of leukocyte activity in vivo and in vitro. Front Pharmacol 13:867508, 2022.
Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: An international consensus. Lancet Oncol 12 (5):489-495, 2011.
Zhang D, Ji Y, Lv L, et al. An overview of systematic reviews and meta-analyses of clinical studies of acupuncture for cancer pain. Integr Cancer Ther 22:15347354231210288, 2023.
Smith SM, Schapira L. Racism and health among cancer survivors. Cancer 129(19):2941-2943, 2023.
Wang L, Chang EW, Wong SC, et al. Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins. J Immunol 190(2):794-804, 2021.
Vaupel P, Höckel M, Mayer A. Impact of hemoglobin levels on tumor oxygenation: the higher, the better? Strahlenther Onkol. 182(2):63–71; 2006.
Warburg O. On the origin of cancer cells. Science 123(3191):309-314, 1956.
Chen J, Zou X. Prognostic significance of lactate dehydrogenase and its impact on the outcomes of gastric cancer: A systematic review and meta-analysis. Front Oncol 13:1247444, 2023.
Hwang MA, Won M, Im JY, et al. TNF−α secreted from macrophages increases the expression of prometastatic integrin αV in gastric cancer. Int J Mol Sci 24(1):376, 2023.
Alotaibi AG, Li JV, Gooderham NJ. Tumour necrosis factor-alpha (TNF-α)-induced metastatic phenotype in colorectal cancer epithelial cells: Mechanistic support for the role of microRNA-21. Cancers 15(3):627, 2023.
Zhang Y, Zhang Q, Zhang X. Molecular mechanisms of tumour necrosis factor signalling via TNF receptor 1 and TNF receptor 2 in the tumour microenvironment. Curr Opin Immunol 86:102409, 2023.
Zhou R, Sun J, He C, et al. CCL19 suppresses gastric cancer cell proliferation, migration, and invasion through the CCL19/CCR7/AIM2 pathway. Hum Cell 33(4):1120-1132, 2020.
Xie D, Wang Z, Liu Y. Immunohistochemical techniques and their applications in cancer research. Chin J Cancer Res 30(2):141-154, 2018.
Liang G, Li S, Du W, et al. Hypoxia regulates CD44 expression via hypoxia-inducible factor-1α in human gastric cancer cells. Oncol Lett 13(2):967-972, 2017.
Li H, Wang Y, Li H, et al. Low heme oxygenase-1 expression promotes gastric cancer cell apoptosis, inhibits proliferation and invasion, and correlates with increased overall survival in gastric cancer patients. Oncol Lett 18(6):6167-6175, 2019.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
